A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1186/s13075-016-1020-3
Published Online: 2016-06-10
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buisman, Leander R.
Luime, Jolanda J.
Oppe, Mark
Hazes, Johanna M. W.
Rutten-van Mölken, Maureen P. M. H.
Funding for this research was provided by:
Center for Translational Molecular Medicine (04I-202)
Reumafonds (04I-202)